- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-3-mer
- Ligands
- 14 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.16: 15 residues within 4Å:- Chain B: E.72, M.75, R.235, P.236
- Chain D: X.105, X.106
- Chain E: X.31, X.93, X.94
- Chain G: N.106, S.108, V.129, G.132, S.133, Y.134
2 PLIP interactions:1 interactions with chain G, 1 interactions with chain B- Hydrophobic interactions: G:Y.134
- Hydrogen bonds: B:R.235
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose
NAG.19: 5 residues within 4Å:- Chain A: K.88, N.89, N.90, S.91, H.92
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: N.99, E.100, W.227
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain B: K.88, N.89, H.92
- Chain E: X.97
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain B: G.159, N.224
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain C: N.99
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain C: N.119
Ligand excluded by PLIPNAG.25: 5 residues within 4Å:- Chain C: K.88, N.89, N.90, S.91, H.92
Ligand excluded by PLIPNAG.26: 5 residues within 4Å:- Chain F: C.33, F.34, Y.112, N.114, T.121
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain F: N.131
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain F: N.136, T.138
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain G: L.135, N.136, E.137
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain G: N.131
Ligand excluded by PLIPNAG.31: 6 residues within 4Å:- Chain C: Q.69
- Chain H: K.32, C.33, Y.112, N.114, T.121
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain C: Y.200
- Chain H: N.131
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain H: N.136, E.137, T.138
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brouwer, P.J.M. et al., Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses. Cell Rep (2024)
- Release Date
- 2024-09-25
- Peptides
- Glycoprotein GP1: ABC
Rabbit polyclonal Fv heavy chain: D
Rabbit polyclonal Fv light chain: E
Glycoprotein G2: FGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
LF
aG
bH
c
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-3-mer
- Ligands
- 14 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brouwer, P.J.M. et al., Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses. Cell Rep (2024)
- Release Date
- 2024-09-25
- Peptides
- Glycoprotein GP1: ABC
Rabbit polyclonal Fv heavy chain: D
Rabbit polyclonal Fv light chain: E
Glycoprotein G2: FGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
LF
aG
bH
c